170 results on '"Vogel, Marco M E'
Search Results
2. The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy
3. Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations
4. Mobile applications in radiation oncology—current choices and future potentials
5. Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
6. Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations
7. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
8. SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and Effective
9. Coronavirus disease 2019 and radiation oncology—survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncology
10. European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy
11. Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists
12. Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival
13. A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer
14. Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
15. SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and Effective
16. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
17. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
18. Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival
19. A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer
20. Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
21. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy
22. Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
23. Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
24. Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
25. Mobile applications in radiation oncology—current choices and future potentials
26. Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy
27. Radiotherapy concepts for spinal metastases—results from an online survey among radiation oncologists of the German Society for Radiation Oncology
28. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
29. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
30. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy
31. Coronavirus disease 2019 and radiation oncology—survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncology
32. Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
33. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
34. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma: Hearing preservation and patients’ self-reported outcome based on an established questionnaire
35. PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy
36. 1256: Comparison of ESTRO-ACROP and PERYTON guideline for CTV delineation for salvage radiotherapy
37. 176: Automated CTV delineation for prostate salvage radiotherapy using deep learning
38. Stereotactic Body Radiotherapy (SBRT) für die Behandlung von Knochenmetastasen beim oligometastasierten Prostatakarzinom
39. Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
40. Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
41. Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
42. Combining 68 Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
43. Web-Based Patient Self-Reported Outcome After Radiotherapy in Adolescents and Young Adults With Cancer: Survey on Acceptance of Digital Tools
44. Additional file 1 of A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer
45. Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
46. Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists
47. Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival
48. A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer
49. Web-Based Patient Self-Reported Outcome After Radiotherapy in Adolescents and Young Adults With Cancer: Survey on Acceptance of Digital Tools
50. Web-Based Patient Self-Reported Outcome After Radiotherapy in Adolescents and Young Adults With Cancer: Survey on Acceptance of Digital Tools (Preprint)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.